Dr. Agarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-2428Fax+1 215-349-5923
Summary
- Dr. Manuj Agarwal is a Radiation Oncologist and Longevity Medicine Physician based in the greater Philadelphia region. He specializes in prostate brachytherapy, longevity and rejuvenation.
Education & Training
- Maimonides Medical Center/SUNY Downstate HSUResidency, Radiation Oncology, 2011 - 2015
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 2010 - 2011
- State University of New York Downstate Medical Center College of MedicineClass of 2010
- Binghamton UniversityBA, Cell & Molecular Biology, Asian & Asian-American Studies, 2001 - 2005
Certifications & Licensure
- MD State Medical License 2016 - 2026
- VA State Medical License 2023 - 2026
- CO State Medical License 2024 - 2025
- NJ State Medical License 2023 - 2025
- NV State Medical License 2024 - 2025
- NY State Medical License 2024 - 2025
- PA State Medical License 2018 - 2024
- American Board of Radiology Radiation Oncology
- Join now to see all
Awards, Honors, & Recognition
- Education Grant American Brachytherapy Society, 2014
- Certificate of Merit for Excellence in Gastroenterology New York State Assembly, 2010
- Award for Excellence in Gastroenterology SUNY Downstate Alumni Association, 2010
- Join now to see all
Publications & Presentations
PubMed
- Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured onF-DCFPyL PET/CT.Miles Hsu, Xinhe Shan, Rebecca Zhang, Eva Berlin, Arun Goel
Clinical Genitourinary Cancer. 2024-08-01 - 2 citationsSocial Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer.Biniyam G Demissei, Kyunga Ko, Anran Huang, Daniel J Lee, Abigail G Doucette
JACC. Cardiooncology. 2024-06-01 - 2 citationsUtilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System.Nikhil Yegya-Raman, Cole Friedes, Lova Sun, Michelle Iocolano, Kristine N Kim
Clinical Lung Cancer. 2023-07-01
Journal Articles
- Concordance between prostate needle biopsy and Surgical Histopathology in a Primary African-American PopulationAgarwal M, Chen S, Chhabra A, Rotman M, Schwartz D, Schreiber D, Int J of Surg Path, 1/1/2013
Abstracts/Posters
- Comparison of Outcomes Between Radical Prostatectomy and Dose Escalated Radiation Therapy in a Predominantly African American PopulationAgarwal M, Schwartz D, Schreiber D, National Veterans Administration Research Week, 1/1/2014
- Unilateral Radiotherapy for Node-Positive HPV-Positive Squamous Cell Carcinoma of the Tonsil: Analysis of a Prospective CohortASTRO Annual Meeting, 1/1/2014
- Long Term Tolerance and Outcomes for Dose Escalation in Early Salvage Post-Prostatectomy Radiation TherapySafdieh J, Weiner J, Schwartz D, Navo E, Agarwal M, Rotman M, Schreiber D, ASTRO Annual Meeting, 1/1/2014
- Join now to see all
Press Mentions
- Prostate Cancer Awareness: Understanding Your OptionsSeptember 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: